This week a federal appeals court ruled that off-label drug marketing is protected free speech. The ruling is somewhat controversial, with supports and detractors. Some claim the ruling is a triumph for free speech. Others argue that the ruling will allow the prescription drug industry to promote drugs without restrictions. The pharmaceutical industry is a […]